| Marilu Margarita Jurado, MD | |
|
1611 Nw 12th Ave, Miami, FL 33136-1005 | |
| (305) 585-5215 | |
| Not Available |
| Full Name | Marilu Margarita Jurado |
|---|---|
| Gender | Female |
| Speciality | Endocrinology |
| Experience | 15 Years |
| Location | 1611 Nw 12th Ave, Miami, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245592195 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cleveland Clinic Martin North Hospital | Stuart, FL | Hospital |
| Shands Jacksonville | Jacksonville, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Martin Memorial Physicians Corporation Inc | 7315833555 | 372 |
News Archive
POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, announced today the results of a Phase 1 study, which reported that PA32540, a novel coordinated-delivery tablet of enteric-coated aspirin (325 mg) and immediate-release omeprazole (40 mg), showed no ex vivo drug-drug interaction with clopidogrel when administered 10 hours apart in healthy patients, based on the study's pre-specified analysis.
Stereotaxis, Inc. announced today that the underwriters for the recently announced public offering of Stereotaxis common stock have exercised in full their over-allotment option to purchase an additional 975,000 shares of the Company's common stock. The 7,475,000 shares of Stereotaxis common stock in the offering, including the 975,000 shares subject to the over-allotment option, are being sold at a price to the public of $4.00 per share.
Meda's partner for retigabine, Valeant Pharmaceuticals International, Inc., today announced that the European Commission has granted the marketing authorization for Trobalt™ (retigabine) in the epilepsy therapy area.
A major cause of patient pain and suffering and additional healthcare costs in hospitals and aged care facilities - pressure ulcers (bed sores)- can be more than halved by using a simple but effective bedding overlay product developed by CSIRO.
› Verified 9 days ago
| Entity Name | University Of Florida Jacksonville Physicians, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144276452 PECOS PAC ID: 9133025869 Enrollment ID: O20040128000786 |
News Archive
POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, announced today the results of a Phase 1 study, which reported that PA32540, a novel coordinated-delivery tablet of enteric-coated aspirin (325 mg) and immediate-release omeprazole (40 mg), showed no ex vivo drug-drug interaction with clopidogrel when administered 10 hours apart in healthy patients, based on the study's pre-specified analysis.
Stereotaxis, Inc. announced today that the underwriters for the recently announced public offering of Stereotaxis common stock have exercised in full their over-allotment option to purchase an additional 975,000 shares of the Company's common stock. The 7,475,000 shares of Stereotaxis common stock in the offering, including the 975,000 shares subject to the over-allotment option, are being sold at a price to the public of $4.00 per share.
Meda's partner for retigabine, Valeant Pharmaceuticals International, Inc., today announced that the European Commission has granted the marketing authorization for Trobalt™ (retigabine) in the epilepsy therapy area.
A major cause of patient pain and suffering and additional healthcare costs in hospitals and aged care facilities - pressure ulcers (bed sores)- can be more than halved by using a simple but effective bedding overlay product developed by CSIRO.
› Verified 9 days ago
| Entity Name | Martin Memorial Physicians Corporation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578505228 PECOS PAC ID: 7315833555 Enrollment ID: O20040225000440 |
News Archive
POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, announced today the results of a Phase 1 study, which reported that PA32540, a novel coordinated-delivery tablet of enteric-coated aspirin (325 mg) and immediate-release omeprazole (40 mg), showed no ex vivo drug-drug interaction with clopidogrel when administered 10 hours apart in healthy patients, based on the study's pre-specified analysis.
Stereotaxis, Inc. announced today that the underwriters for the recently announced public offering of Stereotaxis common stock have exercised in full their over-allotment option to purchase an additional 975,000 shares of the Company's common stock. The 7,475,000 shares of Stereotaxis common stock in the offering, including the 975,000 shares subject to the over-allotment option, are being sold at a price to the public of $4.00 per share.
Meda's partner for retigabine, Valeant Pharmaceuticals International, Inc., today announced that the European Commission has granted the marketing authorization for Trobalt™ (retigabine) in the epilepsy therapy area.
A major cause of patient pain and suffering and additional healthcare costs in hospitals and aged care facilities - pressure ulcers (bed sores)- can be more than halved by using a simple but effective bedding overlay product developed by CSIRO.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marilu Margarita Jurado, MD 1400 Nw 10th Ave Apt 1603, Miami, FL 33136-1034 Ph: (786) 210-5543 | Marilu Margarita Jurado, MD 1611 Nw 12th Ave, Miami, FL 33136-1005 Ph: (305) 585-5215 |
News Archive
POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, announced today the results of a Phase 1 study, which reported that PA32540, a novel coordinated-delivery tablet of enteric-coated aspirin (325 mg) and immediate-release omeprazole (40 mg), showed no ex vivo drug-drug interaction with clopidogrel when administered 10 hours apart in healthy patients, based on the study's pre-specified analysis.
Stereotaxis, Inc. announced today that the underwriters for the recently announced public offering of Stereotaxis common stock have exercised in full their over-allotment option to purchase an additional 975,000 shares of the Company's common stock. The 7,475,000 shares of Stereotaxis common stock in the offering, including the 975,000 shares subject to the over-allotment option, are being sold at a price to the public of $4.00 per share.
Meda's partner for retigabine, Valeant Pharmaceuticals International, Inc., today announced that the European Commission has granted the marketing authorization for Trobalt™ (retigabine) in the epilepsy therapy area.
A major cause of patient pain and suffering and additional healthcare costs in hospitals and aged care facilities - pressure ulcers (bed sores)- can be more than halved by using a simple but effective bedding overlay product developed by CSIRO.
› Verified 9 days ago
Dr. Rhea Bettina Sancassani, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1801 Nw 9th Ave Ste 209, Miami, FL 33136 Phone: 786-466-8490 Fax: 305-573-6562 | |
Mrs. Dania M Verdecia, ARNP Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 11880 Bird Road, Suit 411, Miami, FL 33175 Phone: 305-223-1959 Fax: 305-220-7102 | |
Jacklyn Reyes Pancrudo, D.O. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 11750 Sw 40th St, Miami, FL 33175 Phone: 561-997-0821 | |
Ms. Madeline De Los Milagros Castro, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 971 Nw 2nd St, Miami, FL 33128 Phone: 305-545-7737 | |
Irwin Singer, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1201 Nw 16th St, Miami, FL 33125 Phone: 305-575-3160 | |
Dr. Manrique Oscar Iriarte, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 12750 Nw 17th St, Miami, FL 33182 Phone: 305-781-4815 | |
Dr. Gianluca Iacobellis, M.D. PH.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1450 Nw 10th Ave, Miami, FL 33136 Phone: 305-243-3636 Fax: 305-243-6575 |